Related Experiment Video
Updated: Dec 30, 2025
Models of Murine Vaginal Colonization by Anaerobically Grown Bacteria
Published on: May 25, 2022
Vaginal Microbiota Transplantation: The Next Frontier
Kevin DeLong1, Fareeha Zulfiqar1, Diane E Hoffmann1
1Kevin DeLong, Ph.D., is at the Center for Nanomedicine, Department of Ophthalmology, The Wilmer Eye Institute, Johns Hopkins University School of Medicine. Fareeha Zulfiqar, Ph.D., is at the Center for Nanomedicine, Department of Ophthalmology, The Wilmer Eye Institute, Johns Hopkins University School of Medicine. Diane E. Hoffmann, J.D., is at the University of Maryland Francis King Carey School of Law. Anita J. Tarzian, Ph.D., R.N., is at the University of Maryland Francis King Carey School of Law and the School of Nursing. Laura M. Ensign, Ph.D., is at the Center for Nanomedicine, Department of Ophthalmology, The Wilmer Eye Institute, Johns Hopkins University School of Medicine, Departments of Gynecology and Obstetrics, Infectious Diseases, Pharmacology and Molecular Sciences, and Oncology, Johns Hopkins University School of Medicine, and the Departments of Chemical & Biomolecular Engineering and Biomedical Engineering, Johns Hopkins University.
Vaginal microbiota transplantation (VMT) shows promise for treating conditions like bacterial vaginosis (BV). This article explores VMT
Area of Science:
- Microbiology
- Gastroenterology
- Gynecology
Background:
- Fecal microbiota transplantation (FMT) is effective for Clostrioides difficile infection (CDI).
- This success fuels interest in microbiota transplantation for other conditions.
- The vaginal microbiome's role in health is increasingly recognized.
Purpose of the Study:
- To explore vaginal microbiota transplantation (VMT) as a potential therapeutic approach.
- To identify key challenges in the medical, regulatory, and ethical domains of VMT.
- To discuss the potential application of VMT in treating bacterial vaginosis (BV).
Main Methods:
- Comparative analysis of VMT and FMT clinical aspects.
- Discussion of anticipated clinical trial contexts for VMT.
- Identification of potential research design and regulatory considerations.
Main Results:
- Vaginal microbiota transplantation (VMT) is presented as the next frontier in transplantation therapies.
- Bacterial vaginosis (BV) recurrence prevention is identified as a primary clinical trial focus for VMT.
- Similarities and differences between VMT and FMT are highlighted to inform future research and regulation.
Conclusions:
- VMT holds significant therapeutic potential, particularly for gynecological conditions like BV.
- Addressing medical, regulatory, and ethical challenges is crucial for VMT advancement.
- Comparative insights from FMT research will guide VMT's clinical development and regulatory pathways.
Related Concept Videos
01:29Microorganisms in Medicine and Therapeutics
01:29Bacterial Flora of the Large Intestine
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
01:18Surface Membrane Barriers
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
01:33Bacterial Transformation
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
01:26Bacterial Phylum Verrucomicrobiota